PA
$47.50
+0.74
(+1.58%)
As of Oct 22, 2026, 9:33 PM EDT · cached
Price history
Pacs Group Inc (PACS) is trading up at $47.50 (+1.58%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
IPO: April 11, 2024 · $21.00 offering · NYSE · View IPO details →
Pacs Group Inc revenue & net income history (FY2022–FY2025)
RevenueNet incomeNet margin (right axis, %)
| FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $2.42B | $3.11B | $4.09B | $5.29B |
| Growth (year over year) | — | +28.5% | +31.4% | +29.3% |
| Gross profit | $560.7M | $663.8M | $792.6M | $1.16B |
| Gross margin | 23.1% | 21.3% | 19.4% | 21.9% |
| Operating income | $229.4M | $207.8M | $123.1M | $309.6M |
| Operating margin | 9.5% | 6.7% | 3.0% | 5.9% |
| Net income | $150.5M | $112.9M | $55.8M | $191.5M |
| Net margin | 6.2% | 3.6% | 1.4% | 3.6% |
| EPS (diluted) | $1.17 | $0.88 | $0.38 | $1.22 |
| Balance sheet | ||||
| Cash and equivalents | $58.3M | $73.4M | $157.7M | $197.0M |
| Total assets | — | $3.51B | $5.24B | $5.58B |
| Total liabilities | — | $3.41B | $4.53B | $4.63B |
| Long-term debt | — | $195.7M | $251.0M | $244.8M |
| Shareholders' equity | $68.7M | $96.1M | $709.6M | $946.8M |
| Cash flow | ||||
| Operating cash flow | $92.6M | $63.7M | $367.3M | $404.2M |
| Dividends paid | $60.3M | $80.4M | $33.7M | $0 |
RevenueNet incomeNet margin (right axis, %)
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.03B | $1.21B | $1.28B | $1.31B | $1.34B | $1.36B | $1.42B | $1.43B |
| Growth (year over year) | +30.0% | +41.6% | +38.8% | +39.9% | +31.0% | +12.4% | +11.2% | +9.1% |
| Gross profit | $176.7M | $258.5M | $253.4M | $288.4M | $298.3M | $319.2M | $346.0M | $338.5M |
| Gross margin | 17.2% | 21.4% | 19.8% | 22.0% | 22.2% | 23.5% | 24.4% | 23.7% |
| Operating income | $23.0M | $72.0M | $48.1M | $80.5M | $86.3M | $94.7M | $120.0M | $109.3M |
| Operating margin | 2.2% | 6.0% | 3.8% | 6.1% | 6.4% | 7.0% | 8.5% | 7.7% |
| Net income | $15.6M | $37.2M | $28.5M | $51.0M | $52.4M | $59.7M | $80.7M | $76.4M |
| Net margin | 1.5% | 3.1% | 2.2% | 3.9% | 3.9% | 4.4% | 5.7% | 5.3% |
| EPS (diluted) | $0.10 | $0.22 | $0.17 | $0.31 | $0.32 | $0.42 | $0.50 | $0.47 |
| Balance sheet | ||||||||
| Cash and equivalents | $49.5M | $157.7M | $287.5M | $294.2M | $355.7M | $197.0M | $248.0M | $164.5M |
| Total assets | $4.52B | $5.24B | $5.49B | $5.50B | $5.63B | $5.58B | $5.66B | $5.66B |
| Total liabilities | $3.85B | $4.53B | $4.74B | $4.69B | $4.75B | $4.63B | $4.62B | $4.54B |
| Long-term debt | $253.6M | $251.0M | $249.1M | $247.0M | $245.9M | $244.8M | $239.8M | $238.7M |
| Shareholders' equity | $660.0M | $709.6M | $750.2M | $806.8M | $871.3M | $946.8M | $1.04B | $1.11B |
| Cash flow | ||||||||
| Operating cash flow | $209.2M | $64.6M | $150.2M | $52.6M | $204.8M | −$3.39M | $236.3M | $135.5M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 | $0 | — | — |
From Pacs Group Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Pacs Group Inc
- Headquarters
- Salt Lake City, Utah From SEC filings, Oct 2026
Recent News (7)
-
PACS Group CEO Jason Murray sells $2.18m in company stock
PACS Group CEO Jason Murray sells $2.18m in company stock
-
Democrats — and Elon Musk — continue to dominate midterm campaign fundraising Democratic candidates are on offense with fundraising, and Republican super PACs continue to play defense heading into the final weeks of the midterm.
-
PACS Group president & COO Joshua Jergensen sells $1.78M in stock
PACS Group president & COO Joshua Jergensen sells $1.78M in stock
-
PACS Group CEO Hulse sells $5.6m in PACS stock
PACS Group CEO Hulse sells $5.6m in PACS stock
-
Talarico compares campaign to biblical David Democrat James Talarico compared his campaign to biblical figure David, saying he was “going up against our own Goliaths,” ahead of his battleground contest against Texas Attorney General Ken Paxton i…
-
Musk gives GOP a boost ahead of the midterms {beacon} Technology Technology The Big Story Musk gives GOP a boost ahead of the midterms Tech trillionaire Elon Musk gave $276 million to several Republican super PACs and organizations over the p…
-
Musk throws $276M behind Republicans in midterms Tech trillionaire Elon Musk gave $276 million to several Republican super PACs and organizations over the past three months, as the GOP faces headwinds ahead of the midterm elections. This brings the …
More Health Care stocks
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- ALNY Alnylam Pharmaceuticals
- AMGN Amgen
- BAX Baxter International